USPTO serial 97822119
IMPERATIVE CARE
Reviewed by CopyMark Law Group
Status 733Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- WATSON, BRIDGET ANNE
- Law office
- TMO LAW OFFICE 137
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with IMPERATIVE CARE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*
Plus Government fees of $450
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Steven J. Nataupsky
Steven J. Nataupsky KNOBBE, MARTENS, OLSON & BEAR, LLP2040 MAIN STREET, 14TH FLOORIRVINE, CA 92614United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical devices, namely, catheters, stents, guidewires, drug delivery systems, wearable monitors for monitoring vital signs, stroke rehabilitation devices in the nature of physical, cognitive, and speech-language-pathology rehabilitation devices; Digital health devices in the nature of digital monitoring devices, for use in telemedicine, and for use in behavioral health and community health, for monitoring biomarkers of patients; Medical devices for the detection, diagnosis, and treatment of strokes, and physical and neuro rehabilitation devices for use with stroke patients; Medical catheters and medical catheter sheaths for use in dialysis and treating deep vein thrombosis, coronary occlusions, and peripheral artery occlusions; Medical, surgical and healthcare apparatus and instruments, namely, thrombus removal devices, clot removal devices, emboli removal devices, catheters, catheters for treating deep vein thrombosis, catheters for treating peripheral arterial occlusions, dialysis catheters, aspiration control handles, vacuum pumps, tubing sets comprised of medical tubing for use with catheters, blood filters, and parts and fittings for the aforementioned goods; Medical, surgical and healthcare apparatus and instruments, namely, medical and surgical apparatus and instruments for use in thrombus clot, clot, and emboli removal; Catheters; Catheters for treating pulmonary embolisms and deep vein thrombosis; Catheters used in dialysis; Catheters for treating peripheral arterial occlusions; Catheters for treating coronary occlusions; Medical devices, namely, aspiration control handles; Vacuum pumps for medical purposes; Tubing sets comprised of medical tubing for removal of blood and thrombus, aspiration, and removing occlusions, filters and parts and fittings for the aforementioned goods; Robotic devices for use in connection with transvascular medical procedures; Robotic catheter drive systems comprised of a motorized catheter positioner having rotational and translational movement capability and a tele-robotic controller with rotation, translation and deflection control buttons, to facilitate remote catheterizations, for use in transvascular medical procedures; Robotic guidewire drive systems for use in transvascular medical procedures; Medical devices for automated movement in the nature of a robotic system comprising motors having rotational and/or translational movement capability for use in robotic control of catheters and/or guidewires; Surgical instruments and apparatus for use in transvascular medical procedures, namely, computerized surgical control systems comprising a medical endoscope, computer hardware, and installed firmware for controlling and operating surgical robots and surgical instruments | ACTIVE | — |
| 012 | Surgical carts for use in transvascular medical procedures | ACTIVE | — |
| 044 | Medical services; Medical services in connection with the detection, diagnosis, treatment and physical and neuro rehabilitation of stroke patients; Holistic health services; Providing health care services in the field of vascular disease and strokes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Imperative Care, Inc.
- Other trademarks owned by Imperative Care, Inc.
- Other trademarks in Class 010
- Other trademarks in Class 012
- Other trademarks in Class 044
- Similar marks named IMPERATIVE CARE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 6, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 5, 2026 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Nov 5, 2026 | EXT4 | SOU EXTENSION 4 FILED | — |
| Nov 5, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 19, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 18, 2026 | EX3G | SOU EXTENSION 3 GRANTED | — |
| May 18, 2026 | EXT3 | SOU EXTENSION 3 FILED | — |
| May 18, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 3, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 2, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Dec 2, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| Dec 2, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 2, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 1, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| May 1, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| May 1, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 3, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 22, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 22, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 2, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 12, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 10, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 10, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 10, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 21, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 21, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 21, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 16, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 5, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 4, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 4, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 4, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Mar 4, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Dec 4, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 4, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 4, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 1, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 23, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 7, 2023 | NWAP | NEW APPLICATION ENTERED | — |